文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

2008至2021年美国接受机械通气的ICU患者物理治疗与作业治疗使用趋势

Trends of Physical and Occupational Therapy Utilization in ICU Patients Undergoing Mechanical Ventilation in the United States: 2008-2021.
PubMed 文献 · Crit Care Med · 2025-07-23
一句话结论2008至2021年间,接受有创机械通气成人中早期物理治疗/作业治疗使用率在2019年前上升后于2020、2021年下降,医院间差异近3倍。

该回顾性研究基于Premier医疗数据库2008至2021年814家医院、1,228,909例住院第3天前开始有创机械通气且持续3至14天的成人住院记录,评估机械通气前3天内物理治疗/作业治疗(PT/OT)使用趋势。早期PT/OT总体使用率为9.7%,从2008年8.5%升至2019年10.8%(趋势P<0.001),2020年降至9.5%、2021年降至8.9%。多变量调整后,2016年较2008年使用几率增加(aOR 1.52,95%CI 1.46-1.59),2020年(aOR 1.23,95%CI 1.18-1.29)和2021年(aOR 1.20,95%CI 1.15-1.26)下降但仍高于2008年。出院医院是高使用与低使用差异的重要因素(mOR 2.82,95%CI 2.67-2.97)。

要点

  • 814家医院1,228,909例住院第3天前开始有创机械通气且持续3至14天的成人中,仅9.7%(118,662例)在机械通气前3天内接受PT/OT。
  • 早期PT/OT使用率从2008年8.5%升至2019年10.8%(趋势P<0.001),2020年降至9.5%、2021年降至8.9%。
  • 调整后2016年较2008年接受早期PT/OT的几率增加(aOR 1.52,95%CI 1.46-1.59),2020年(aOR 1.23,95%CI 1.18-1.29)和2021年(aOR 1.20,95%CI 1.15-1.26)下降但仍高于2008年。
  • 医院间早期PT/OT使用率中位数5.4%(四分位距2.9-11.0%),高使用医院较低使用医院接受早期PT/OT的几率近3倍(mOR 2.82,95%CI 2.67-2.97)。
  • 出院医院是决定机械通气期间是否接受PT/OT的重要因素。

适用人群与场景

  • Premier医疗数据库医院2008至2021年住院的成人,住院第3天前开始有创机械通气且持续机械通气3至14天。

研究设计与关键结果

  • 回顾性研究,基于Premier医疗数据库814家医院,纳入1,228,909例住院第3天前开始有创机械通气且持续3至14天的成人住院记录。
  • 主要结局为机械通气前3天内PT/OT使用(早期PT/OT),118,662例(9.7%)接受早期PT/OT。
  • 早期PT/OT使用率从2008年8.5%升至2019年10.8%(趋势P<0.001),2020年降至9.5%、2021年降至8.9%。
  • 医院间早期PT/OT使用率中位数5.4%(四分位距2.9-11.0%)。
  • 多变量调整后(出院医院为随机效应),2016年较2008年接受早期PT/OT的aOR为1.52(95%CI 1.46-1.59),2020年aOR为1.23(95%CI 1.18-1.29),2021年aOR为1.20(95%CI 1.15-1.26)。
  • 高使用医院较低使用医院接受早期PT/OT的几率近3倍(mOR 2.82,95%CI 2.67-2.97)。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Physical and occupational therapy (PT/OT) during invasive mechanical ventilation (IMV) may improve outcomes, however, utilization patterns are understudied.

OBJECTIVES: Determine trends over time and by hospital in PT/OT utilization.

DESIGN: Retrospective study.

SETTING: Premier Healthcare Database hospitals (2008-2021).

PATIENTS: Adults beginning IMV by hospitalization day 3 and receiving IMV continuously for 3-14 days.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: The primary outcome was PT/OT usage within the first 3 days of IMV (early PT/OT). Cochran-Armitage tests were used to evaluate unadjusted trends across discharge years. A multilevel multivariable logistic regression model was then created with discharge hospital as a random effect and clinical, sociodemographic, and hospital characteristics as covariables. The median odds ratio (mOR) was calculated to quantify the association of discharge hospital with PT/OT utilization. Across 814 hospitals, 1,228,909 early IMV hospitalizations were identified. Of those, 118,662 (9.7%) had early PT/OT. Frequency of early PT/OT rose from 2008 to 2019 (8.5-10.8%; ptrend < 0.001) before declining in 2020 (9.5%) and 2021 (8.9%). Across hospitals, median early PT/OT usage was 5.4% (interquartile range, 2.9-11.0%). After multivariable adjustment, patients were increasingly more likely to get early PT/OT every year until 2016 (adjusted odds ratio [aOR] for 2016 vs. 2008, 1.52; 95% CI, 1.46-1.59). Use then remained relatively flat until 2020 when it began to decline (aOR for 2020, 1.23; 95% CI, 1.18-1.29 and aOR for 2021, 1.20; 95% CI, 1.15-1.26). The odds of receiving early PT/OT in higher use hospitals was nearly three-fold higher than in lower use hospitals (mOR, 2.82; 95% CI, 2.67-2.97).

CONCLUSIONS: Early PT/OT usage rose during the early period, before declining significantly in 2020 and 2021. However, use in 2020 and 2021 remained higher than in 2008. Individual hospital of discharge was an important factor in determining who got PT/OT during IMV.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Mintz J, Mustafa M, Puthumana RM, et al. Trends of Physical and Occupational Therapy Utilization in ICU Patients Undergoing Mechanical Ventilation in the United States: 2008-2021. Crit Care Med. 2025. PMID: 40699013. doi:10.1097/CCM.0000000000006795

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。